|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 9 of 19 found articles
| Title: |
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study |
| Author: |
Psyrri, A. Fayette, J. Harrington, K. Gillison, M. Ahn, M.-J. Takahashi, S. Weiss, J. Machiels, J.-P. Baxi, S. Vasilyev, A. Karpenko, A. Dvorkin, M. Hsieh, C.-Y. Thungappa, S.C. Segura, P.P. Vynnychenko, I. Haddad, R. Kasper, S. Mauz, P.-S. Baker, V. He, P. Evans, B. Wildsmith, S. Olsson, R.F. Yovine, A. Kurland, J.F. Morsli, N. Seiwert, T.Y. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 34 () nr. 3 pages 262-274 |
| Year: |
2023 |
| Contents: | |
| Publisher: |
The Authors |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 9 of 19 found articles
| << previous | next >> |